Acefylline Market - Forecast(2024 - 2030)

Acefylline Market Overview

Acefylline market size is projected to grow at a CAGR of 2.1% during the forecast period 2022-2027. Acefylline also referred to as acetyloxytheophylline, is a xanthine chemical class stimulant. It acts by blocking adenosine receptors. It's combined with diphenhydramine in the pharmaceutical etanautine to help counteract the drowsiness caused by diphenhydramine. The growth can be attributed to the increasing demand for asthma agents from pharmaceutical industry across various regions globally. The accelerating demand for skin conditioning products in various regions is further assisting the gacefylline market growth during the forecast period. However, the use of acefylline as a bronchodilator agent is being banned in various regions gradually over the coming years, which is anticipated to impede the acefyllines market growth over the forecast period.

COVID-19 Impact

The outbreak of COVID-19 had an impact on the world economy and demand in major industries all over the world. The pandemic scenario culminated in a worldwide lockdown and confinement of industrial operations, commodities, supply-chain instability, and other activities. The key acefylline end industries were also influenced by this situation. The acefylline market's growth slowed in 2020 due to slow demand from end-use industries. In the fourth quarter of 2020, the market, on the other hand, was recovering, and businesses resumed operations with reduced capacity and under government guidelines. However, all end-use industries were fully operational by the beginning of 2021, resulting in high demand for acefylline, as a result, the market is expected to grow at a rapid rate over the forecast period.

Report Coverage

The report: “Acefylline Market Report – Forecast (2022-2027)”, by IndustryARC, covers an in-depth analysis of the following segments of the Acefylline market.

Key Takeaways

• Asia-Pacific dominates the acefylline market, owing to the increasing medical & healthcare industry in the region. The increasing per capita income and evolving lifestyle of individuals coupled with the rising population are the major factors expanding the medical & healthcare industry in APAC.
• The rate of asthma patients has been surging around the globe. This factor is anticipated to significantly contribute toward market growth over the forecast period.
• However, the side effects of acefylline-based medications are acting as a major challenge for the Acefyllines market during the forecast period.

Acefylline Market Segment Analysis – By Packaging

The drum segment held the largest share in the acefylline market in 2021 and is forecasted to grow at a CAGR of 2.5% during the forecast period 2022-2027. Drums, such as plastic, steel, and fiber drums, are ideal for storing and transporting acefylline. Because bottles and bags are less capable of holding or transferring toxic or hazardous materials, steel and plastic drums are frequently used for acefylline packaging. Because of their versatility, steel and fiber drums are an excellent choice for storing and transporting large quantities of acefylline. They're also simple to palletize and wrap, making them an excellent choice for acefylline bulk shipping. All of these advantages of using plastic, steel, and fiber drums as packaging are gaining segment traction.

Acefylline Market Segment Analysis – By End-Use Industry

The medical & healthcare segment held the largest share in the acefylline market in 2021 and is forecasted to grow at a CAGR of 3.6% during the forecast period 2022-2027, owing to increasing usage of acefylline as a pharmaceutical ingredient. Acefylline is recommended for treating asthma, emphysema, and acute and chronic bronchitis associated with bronchospasm. It acts as an adenosine receptor antagonist, owing to which this medicine is used for treating symptoms of asthma and other breathing problems such as bronchitis [infection of the respiratory tract (bronchioles)] and bronchial asthma (breathing disorder). Furthermore, acefylline relaxes smooth muscles, relieves bronchospasm & has a stimulant effect on respiration. Due to this extensive characteristic of acefylline, it is being widely used in the medical & healthcare sector, which is anticipated to drive the acefylline market during the forecast period.

Acefylline Market Segment Analysis – By Geography

Asia-Pacific region held a significant share in the acefylline market in 2021 up to 42% and is forecasted to grow at a CAGR of 4.2% during the forecast period 2022-2027, owing to the increasing prevalence of chronic respiratory disease in APAC countries. For instance, in India, chronic respiratory conditions affect approximately 93 million people, with nearly 37 million of them being asthmatics. India accounts for 11.1 percent of the global asthma burden and over 42% of asthma-related deaths, making it the world's asthma capital. According to globalasthmareport.org, asthma affects about 6% of children and 2% of adults in India's 1.31 billion people. Despite improvements, the 2017-2018 Global Asthma Network (GAN) survey in Thailand found that asthma prevalence in children is still over 10%, with severe wheeze prevalence at 2%. The World Health Survey (WHS), a standardized questionnaire developed by the World Health Organization (WHO), gathered information on the prevalence of a variety of medical conditions among adults aged 18 to 45 years in a variety of countries around the world. Australia (21.5%), Sweden (20.2%), the United Kingdom (18.2%), the Netherlands (15.3%), and Brazil (21.5%) had the highest prevalence of clinical asthma. Thus, the demand for chronic respiratory medicines in the region is being aided by the prevalence of chronic respiratory disease in APAC, thereby dominating the acefylline market in the Asia-Pacific region.

Acefylline Market Drivers

Growing Chronic Respiratory Diseases

Asthma is a major chronic respiratory disease, affecting both children and adults. According to the World Health Organization (WHO), in 2019, approximately 262 million people were afflicted by asthma, culminating in 461000 deaths. According to the Centers for Disease Control and Prevention (CDC), asthma affects about one in every twelve people in the United States or approximately 25 million people. And it appears that the rate is rising. In 2016, asthma accounted for 9.8 million doctor's office visits, according to the Asthma and Allergy Foundation of America (AAFA). Asthma was responsible for 178,530 hospital inpatient discharges and 1.6 million emergency department visits in 2018. In 2019, 44.3 percent of asthmatic children aged 18 and under said they had one or more asthma symptoms in the previous year. The increasing asthma cases are set to increase the demand for asthma medication in the medical & healthcare sector, and further drive the acefylline market growth during the forecast period.

Increasing Demand for Skin Nourishment Products

Acefylline is often used in skin conditioners. Ictyane Hydra - Light Face Cream, and Ictyane Night - Ictyane Regenerating Night Care are a few illustrations that have acefylline in their product ingredients. The skincare industry has witnessed an increasing demand for its products in various regions. The demand for skin nourishment products has increased as a result of rising concerns about skin nourishment caused by a variety of factors such as the increased occurrence of acne, black spots, scars, dullness, and tanning. Consumer spending patterns on premium beauty care products are expected to change, supporting the market's overall growth. As a result of these factors, male end users have increased their demand for products like fairness creams and aftershave creams. According to the Men Grooming Survey 2019 conducted by Prima & Prep, 89.5 percent of men are concerned about skin issues, and 35.8% of men use skin nourishment and anti-aging items regularly. Since the skin nourishment segment is booming, the demand for its chemical ingredients such as acefylline is also significantly increasing. Thus, the increasing demand for skin nourishment acts as a driver for the acefylline market during the forecast period.

Acefylline Market Challenges

Side Effects of Acefylline

Acefylline medicine can have some unwanted side effects in addition to its beneficial effects. Even though not all of these side effects are likely to occur, if they do, medical attention may be required. Blurred vision, clumsiness, a crawling or tingling sensation on the skin, fever, irregular, twisting movement, especially of the face, arms, and legs, joint pain, skin rash or itching, and more are all rare side effects. Abdominal or stomach cramps or pain, diarrhea, dizziness, drowsiness, headache, muscle weakness, nausea or vomiting, tremors, and other side effects are less common. Thus, such side effects of acefylline-based medicines are anticipated to hamper the acefylline market growth.

Acefylline Industry Outlook

Technology launches, acquisitions, and R&D activities are key strategies adopted by players in the acefylline market. Global acefylline market top 10 companies are:

1. 3B Scientific
2. AlliChem
3. Alfa Chemistry
4. Merck & Co., Inc
5. Cheng Du Micxy Chemical
6. Waterstone Technology
7. Hangzhou Yuhao Chemical Technology
8. Chengdu XiYa Chemical Technology
9. Wuhan Fortuna Chemical
10. Xilamen Flint Chemical

Relevant Reports

Asthma and Copd Devices Market – Forecast (2022 - 2027)

Report Code: HCR 84738

Salmeterol Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth, and Forecast 2022-2027

Report Code: HCR 35121

Asthma Therapeutics Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth, and Forecast 2021 - 2026

Report Code: CMR HCR 78621

For more Lifesciences and Healthcare Market reports, please click here